Description
Caja con 8 tabletas
indicado principalmente para la prevención del rechazo de órganos en pacientes sometidos a trasplante renal
MYRBETRIC® contiene mirabegrón
Vía de administración: Tópica
PRINCIPIO ACTIVO: NORETISTERONA ENANTATO
CRIAM 400MG LP TAB C20 CARBOHIDRATOS 1.00 UN PROTEINAS 4.00 S/G Caja con 8 tabletasPRINCIPIO ACTIVO: VALPROATO DE MAGENSIO DOSIS: 400 MG FORMA FARMACUTICA: 20 TABLETAS PRESENTACIN: 1 CAJA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
